Literature DB >> 8710173

Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain.

K Saito1, K Suyama, K Nishida, Y Sei, A S Basile.   

Abstract

The effects of transient global ischemia using bilateral carotid artery occlusion on regional cytokine levels in gerbil brain were investigated using enzyme-linked immunoassay techniques. Brain concentrations of interleukin-6 (IL-6), interleukin-1 beta (IL-1 beta), and tumor necrosis factor-alpha (TNF-alpha) were increased during the early recirculation period ( < 6 h) after 10 min of ischemia, with lesser degrees of elevation following only 5 min of ischemia. TNF-alpha levels in the hippocampus and striatum were significantly increased as early as 1 h after recirculation, declining sharply to control levels by 12 h, then transiently increasing at 24 h. Elevated levels of IL-1 beta and IL-6 were not seen until 3-6 h post-occlusion. No significant increases in cytokine concentrations were observed in the cerebellum or thalamus. These results suggest that regionally selective increases in cytokines may be involved in the pathophysiological changes in hippocampus and striatum following transient cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710173     DOI: 10.1016/s0304-3940(96)12460-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  68 in total

Review 1.  Humoral sleep regulation; interleukin-1 and tumor necrosis factor.

Authors:  Kathryn A Jewett; James M Krueger
Journal:  Vitam Horm       Date:  2012       Impact factor: 3.421

2.  Gemfibrozil pretreatment affecting antioxidant defense system and inflammatory, but not Nrf-2 signaling pathways resulted in female neuroprotection and male neurotoxicity in the rat models of global cerebral ischemia-reperfusion.

Authors:  Fatemeh Mohagheghi; Leila Khalaj; Abolhassan Ahmadiani; Behrouz Rahmani
Journal:  Neurotox Res       Date:  2012-07-07       Impact factor: 3.911

3.  Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Brain Res       Date:  2007-01-03       Impact factor: 3.252

4.  K(+) channel blocker-induced neuroinflammatory response and neurological disorders: immunomodulatory effects of astaxanthin.

Authors:  Nesrine Sifi; Marie-France Martin-Eauclaire; Fatima Laraba-Djebari
Journal:  Inflamm Res       Date:  2016-04-06       Impact factor: 4.575

5.  Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1.

Authors:  Gabriel S Chiu; Diptaman Chatterjee; Patrick T Darmody; John P Walsh; Daryl D Meling; Rodney W Johnson; Gregory G Freund
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

6.  Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemia.

Authors:  Tamer Altay; Bethann McLaughlin; Jane Y Wu; T S Park; Jeffrey M Gidday
Journal:  Exp Neurol       Date:  2007-07-26       Impact factor: 5.330

Review 7.  Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders.

Authors:  Rao Muralikrishna Adibhatla; J F Hatcher
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

Review 8.  The expanding interleukin-1 family and its receptors: do alternative IL-1 receptor/signaling pathways exist in the brain?

Authors:  Herve Boutin; Ian Kimber; Nancy J Rothwell; Emmanuel Pinteaux
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

9.  The role of SRC kinase in the caspase-1 pathway after hypoxia in the brain of newborn piglets.

Authors:  Dimitrios Angelis; Tania D Fontánez-Nieves; Maria Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2014-08-06       Impact factor: 3.996

10.  Cerebroprotective effect of resveratrol through antioxidant and anti-inflammatory effects in diabetic rats.

Authors:  Orsu Prabhakar
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-24       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.